On TVN24 in Poland Baxter has admitted they contaminated 72 KG of vaccine material with the live bird flu virus.
As a result of handling this contaminated material in February, 36 people working for the labs Avir and BioTest had to be treated preventatively for the bird flu in hospitals in Austria and the Czech Republic, underlining that their health was threatened by the material in the opinion of medical experts.
Both Avir and BioTest have stated that the final purpose of the contaminated Baxter material was for use in regular seasonal flu vaccines, strongly suggesting the notion it would have been injected into people if it had not been detected by staff at BioTest.
The Times of India reported on March 6th that a global bird flu pandemic had nearly been triggerd by the Baxter material.
Because Baxter is obliged under EU rules to handle the bird flu virus using biosafety level 3 or 4 precautions in its ultra modern biomedical facilities in Austria, an accidental contamination can be virtually ruled out. No evidence has been presented by Baxter to prove otherwise.
Biosafety level 3 regulations apply to any virus that can cause a serious disease in human beings.
The bird flu, a lab engineered virus, has a mortality rate of over 60%.
The gigantic amount of 72 kilos of vaccine material was contaminated in Orth an der Donau.
It is not clear why Baxter had the bird flu virus in its vaccine production facilities in Orth an der Donau in the first place.
WHO supplied the bird flu virus to Baxter. But for what purpose?
It is not clear how the live bird flu virus could have been sent out of the facilities without being radiated (to kill or weaken the virus) and mixed with normal flu material making it an even more potent potential bioweapon under a false label unless it was part of a deliberate plan.
In spite of the overwhelming evidence of a crime that posed a real and deadly danger to the Austrian people, the prosecutor at Korneuburg has dropped the case against Baxter.
As this extract from Wikipedia makes clear, the biosafety level 3 regulations make accidentally contaminating 72 kilos of vaccine material with the live bird flu virus about as easy as it would be to get 72 tonnes of gold out of the high security vault of the Austrian national bank.
“Biosafety level 3
This level is applicable to clinical, diagnostic, teaching, research, or production facilities in which work is done with indigenous or exotic agents which may cause serious or potentially lethal disease after inhalation.
….Laboratory personnel have specific training in handling pathogenic and potentially lethal agents, and are supervised by competent scientists who are experienced in working with these agents. This is considered a neutral or warm zone.
All procedures involving the manipulation of infectious materials are conducted within biological safety cabinets or other physical containment devices, or by personnel wearing appropriate personal protective clothing and equipment. The laboratory has special engineering and design features.
It is recognized, however, that some existing facilities may not have all the facility features recommended for Biosafety Level 3 (i.e., double-door access zone and sealed penetrations). In this circumstance, an acceptable level of safety for the conduct of routine procedures, (e.g., diagnostic procedures involving the propagation of an agent for identification, typing, susceptibility testing, etc.), may be achieved in a biosafety level 2 facility, providing
- the filtered exhaust air from the laboratory room is discharged to the outdoors,
- the ventilation to the laboratory is balanced to provide directional airflow into the room,
- access to the laboratory is restricted when work is in progress, and
- the recommended Standard Microbiological Practices, Special Practices, and Safety Equipment for Biosafety Level 3 are rigorously followed.”